New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo
胰腺神经内分泌癌的新疗法——新兴物质GP-2250和吉西他滨在体外和体内均显示出高效性，且未产生继发性耐药性。
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14112685
Buchholz, Marie; Strotmann, Johanna; Majchrzak-Stiller, Britta; Hahn, Stephan; Peters, Ilka; Horn, Julian; Müller, Thomas; Höhn, Philipp; Uhl, Waldemar; Braumann, Chris
